WINDLAS.NSNSE
Windlas Biotech Limited
₹835.25
ListedAug 16, 2021
SectorHealthcare
IndustryDrug Manufacturers — Specialty & Generic
CountryIndia
Employees-
State-| CityDehradun| Address40/1, Mohabewala Industrial Area| Phone91 135 660 8000
Windlas Biotech Limited, a contract development and manufacturing organization, manufactures and trades in pharmaceutical products in India. The company offers contract manufacturing; customized formulations; contract research and manufacturing services; customized formulation; and regulatory services. It also manufactures tablets, capsules, oral solids, modified-release formulations, chewable and dispersible tablets, customized generics, and complex generics and multi-drug combinations, as well as injectables, including liquid vials, lyophilized vials, and ampoules. In addition, the company offers generic drugs for respiratory, anti-diabetic, gastroenterology, cardiovascular and multivitamin, neuro anti-psychotic, diabetic care, nutraceuticals, nutritional supplement, urology, pain management, and injectable therapies. It also exports generic medicines, health supplements, and custom-branded formulations. Windlas Biotech Limited was incorporated in 2001 and is headquartered in Dehradun, India.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
26.8
?
Div. Rate
₹5.80
?
Div. Yield
0.70%
?
Payout Ratio
18.62%
?
Max Consec. Div. Years
4 years
?
Longest Consec. Div.
4 years
?
Div. Coverage
100%
?
Div. Stability Rate
0.24
?
Div. Growth Rate
100.00%
?
Score
93

Dividend History

Historical dividend payments by ex-dividend date.

Jul 21, 2025
₹ 5.8000
Sep 17, 2024
₹ 5.5000
Sep 5, 2023
₹ 4.0000
Sep 9, 2022
₹ 3.5000

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!